AEON Biopharma, Inc (AEON) insider trading
Every open-market stock purchase and sale by AEON Biopharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Jost Fischer (Insider), $29.3K, 16 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent AEON insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 17, 2026 | Eric G Carter (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Jost Fischer (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Marc Forth (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Robert J Palmisano (Director) | Bought (not open market) | — |
| Jun 17, 2026 | Shelley B Thunen (Director) | Bought (not open market) | — |
| Apr 2, 2026 | John Bencich (CFO) | Bought (not open market) | — |
| Mar 4, 2026 | Alexander Blair Wilson (C-suite exec) | Bought (not open market) | — |
| Mar 4, 2026 | Chad Oh (C-suite exec) | Bought (not open market) | — |
| Mar 4, 2026 | Jennifer Sy (Officer) | Bought (not open market) | — |
| Feb 17, 2026 | Robert E. Bancroft (CEO) | Bought (not open market) | — |
| Feb 17, 2026 | Jennifer Sy (Officer) | Bought (not open market) | — |
| Feb 17, 2026 | Alexander Blair Wilson (C-suite exec) | Bought (not open market) | — |
| Feb 17, 2026 | Chad Oh (C-suite exec) | Bought (not open market) | — |
Who's trading AEON
- Robert J Palmisano, Director: other filings, last Jun 17, 2026
- Eric G Carter, Director: other filings, last Jun 17, 2026
- Shelley B Thunen, Director: other filings, last Jun 17, 2026
- Jost Fischer, Director: other filings, last Jun 17, 2026
- Marc Forth, C-suite exec: other filings, last Jun 17, 2026
- John Bencich, CFO: other filings, last Apr 2, 2026
- Alexander Blair Wilson, C-suite exec: other filings, last Mar 4, 2026
- Chad Oh, C-suite exec: other filings, last Mar 4, 2026
- Jennifer Sy, Officer: other filings, last Mar 4, 2026
- Robert E. Bancroft, CEO: other filings, last Feb 17, 2026
Get free alerts when an insider at AEON Biopharma, Inc files a new trade →